These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26942050)

  • 1. The role of NF-kB in modulating antitumor immunity.
    Richmond A; Yang J
    Oncoimmunology; 2016; 5(1):e1005522. PubMed ID: 26942050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.
    Barberi T; Martin A; Suresh R; Barakat DJ; Harris-Bookman S; Drake CG; Lim M; Friedman AD
    Cancer Immunol Immunother; 2018 Oct; 67(10):1491-1503. PubMed ID: 30030559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth.
    Achyut BR; Angara K; Jain M; Borin TF; Rashid MH; Iskander ASM; Ara R; Kolhe R; Howard S; Venugopal N; Rodriguez PC; Bradford JW; Arbab AS
    Sci Rep; 2017 Oct; 7(1):13754. PubMed ID: 29062041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
    Xu W; Dong J; Zheng Y; Zhou J; Yuan Y; Ta HM; Miller HE; Olson M; Rajasekaran K; Ernstoff MS; Wang D; Malarkannan S; Wang L
    Cancer Immunol Res; 2019 Sep; 7(9):1497-1510. PubMed ID: 31340983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-kappaB activation.
    Chang JH; Ryang YS; Morio T; Lee SK; Chang EJ
    Mol Cells; 2004 Oct; 18(2):177-85. PubMed ID: 15528993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer.
    Zhang M; Chun L; Sandoval V; Graor H; Myers J; Nthale J; Rauhe P; Senders Z; Choong K; Huang AY; Kim J
    Oncoimmunology; 2018; 7(2):e1387347. PubMed ID: 29308312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin inhibits macrophage phagocytosis and enhances inflammatory cytokine production via activation of NF-κB signaling.
    Wang Y; Sun L; Song Z; Wang D; Bao Y; Li Y
    Mol Immunol; 2017 Feb; 82():94-103. PubMed ID: 28064070
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Chu J; Li X; Qu G; Wang Y; Li Q; Guo Y; Hou L; Liu J; Eko FO; He C
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
    Kono Y; Kawakami S; Higuchi Y; Yamashita F; Hashida M
    Biol Pharm Bull; 2014; 37(1):137-44. PubMed ID: 24141263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The procyanidin trimer C1 induces macrophage activation via NF-κB and MAPK pathways, leading to Th1 polarization in murine splenocytes.
    Sung NY; Yang MS; Song DS; Byun EB; Kim JK; Park JH; Song BS; Lee JW; Park SH; Park HJ; Byun MW; Byun EH; Kim JH
    Eur J Pharmacol; 2013 Aug; 714(1-3):218-28. PubMed ID: 23770004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteine Cathepsins in Tumor-Associated Immune Cells.
    Jakoš T; Pišlar A; Jewett A; Kos J
    Front Immunol; 2019; 10():2037. PubMed ID: 31555270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
    Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
    J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-κB Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance.
    Rajalakshmy AR; Malathi J; Madhavan HN
    PLoS One; 2015; 10(5):e0125419. PubMed ID: 25965265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.
    Struzik J; Szulc-Dąbrowska L
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30413032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.
    Sun J; Sun J; Song B; Zhang L; Shao Q; Liu Y; Yuan D; Zhang Y; Qu X
    Sci Rep; 2016 Oct; 6():35855. PubMed ID: 27775051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence linking exposure of fish primary macrophages to antibiotics activates the NF-kB pathway.
    Qiu W; Hu J; Magnuson JT; Greer J; Yang M; Chen Q; Fang M; Zheng C; Schlenk D
    Environ Int; 2020 May; 138():105624. PubMed ID: 32146265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO3-NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function.
    Thompson MG; Larson M; Vidrine A; Barrios K; Navarro F; Meyers K; Simms P; Prajapati K; Chitsike L; Hellman LM; Baker BM; Watkins SK
    J Immunol; 2015 Dec; 195(12):5637-47. PubMed ID: 26561547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy.
    Xiao Z; Su Z; Han S; Huang J; Lin L; Shuai X
    Sci Adv; 2020 Feb; 6(6):eaay7785. PubMed ID: 32076650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.